In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Cleidocranial dysplasia (CCD) is a rare autosomal dominant disorder characterized by skeletal and dental abnormalities primarily, short stature, aplasia or hypoplasia of clavicles, open fontanelles and supernumerary teeth.
📊
Key Findings & Data:Heterozygous mutations of the runt-related transcription factor 2 (RUNX2) gene have been found in approximately 60-70% of cases,leaving a large number of cases with no defined genetic cause which ledus to delve into molecular mechanisms underlying CCD and thus to detect potential target genes to be explored in these patients.
💡
Conclusion & Impact:In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Cleidocranial dysplasia (CCD) is a rare autosomal dominant disorder characterized by skeletal and dental abnormalities primarily, short stature, aplasia or hypoplasia of clavicles, open fontanelles and supernumerary teeth. Heterozygous mutations of the runt-related transcription factor 2 (RUNX2) gene have been found in approximately 60-70% of cases,leaving a large number of cases with no defined genetic cause which ledus to delve into molecular mechanisms underlying CCD and thus to detect potential target genes to be explored in these patients. In this review,we also highlight very broadly the phenotypic characteristics of previously reported patients with CCD.
🔖
Cite This Article
AVENDANO, A., CAMMARATA-SCALİSİ, F., BUDİARDJO, S. B., FAUZİAH, E., GRANDE, N. M., FORTUNATO, L., PLOTİNO, G., YAVUZ, İ., CALLEA, M., RİZAL, M. F. (2022). Cleidocranialdysplasia. Amolecularandclinicalreview. International Dental Research, Cilt: 8 - Sayı: 1, 35–38. https://ajindex.com/articles/539550
Roberts T, Stephen L, Beighton P. Cleidocranial dysplasia: A review of the dental, historical, and practical implications with an overview of the South African experience. Oral Surg Oral Med Oral Pathol Oral Radiol 2013
46–55. [Crossref] 2.Mundlos S. Cleidocranial dysplasia: clinical and molecular genetics. J Med Genet 1999
177–82. 3.Patil P, Barpande S, Bhavthankar J, Humbe J. Cleidocranial dysplasia: A clinico-radiographic spectrum with differential diagnosis. J Orthop Case Reports 2015
21–4. 4.Jensen B. Somatic development in cleidocranial dysplasia. Am J Med Genet 1990
69–74. [Crossref] 5.Komori T. Signaling networks in RUNX2-dependent bone development. J Cell Biochem 2011
750–5. [Crossref] 6.Komori T. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res 2010
189–95. [Crossref] 7.Bharti K, Goswami M. Cleidocranial dysplasia: A report of two cases with brief review. Intractable Rare Dis Res 2016
5(2):117–20. [Crossref] 8.Åberg T, Wang X, Kim J, Yamashiro T, Bei M, Rice R, et al. Runx2 mediates FGF signaling from epithelium to mesenchyme during tooth morphogenesis. Dev Biol 2004
76–93. [Crossref] 9.Zhang Y, Yasui N, Ito K, Huang G, Fujii M, Hanai J, et al. A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc Natl Acad Sci 2000
10549–54.[Crossref] 10.Valenti MT, Dalle Carbonare L, Mottes M. Osteogenic differentiation in healthy and pathological conditions. Int J Mol Sci 2016
e41–9. [Crossref] 11.JarugaA, Hordyjewska E, Kandzierski G, Przemk T. Cleidocraneal dysplasia and RUNX2-clinical phenotype genotype correlation. Clin Genet 2016
393–402. [Crossref] 12.Liu H, Sun Q, Wan C, Li L, Zhang L, Chen Z. MicroRNA-338-3p regulates osteogenic differentiation of mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2. J Cell Physiol 2014
1494–502. [Crossref] 13.Du F, Wu H, Zhou Z, Liu Y. MicroRNA-375 inhibits osteogenic differentiation by targeting runt-related transcription factor 2. Exp Ther Med 2015
207–12. [Crossref] 14.Sera SR, Zur Nieden NI. microRNA regulation of skeletal development. Curr Osteoporos Rep 2017
15(4):353–66. [Crossref] 15. Levanon D, Negreanu V, Bernstein Y, Bar-Am I, Avivi L, Groner Y. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization. Genomics 1994